Artificial intelligence holds great promise in helping healthcare providers gain insight and improve outcomes, whether by enhancing data processing, identifying patterns, or generating insights beyond manual efforts. Regardless of the approach, AI in diagnostics is no longer in its infancy and is expected to experience exponential growth in the next few years.

Join us on August 2 for our first DeviceConnect in nearly two years. We will connect with regional diagnostics experts and key stakeholders from the PNW’s vibrant life sciences community. Explore the opportunities, challenges, and innovative solutions shaping the industry over the next 5-10 years.

DeviceConnect Event Details

🗓 Friday, August 2

🕛 11:30 AM - 1:30 PM

📍Life Science Washington, 188 E Blaine Street

🎟 https://lu.ma/dgldkmiv (free light lunch included!)

Speakers

Scott Thielman (Moderator), CTO and Co-Founder at Product Creation Studio

Scott Thielman is CTO and co-founder of Product Creation Studio. With expertise leading the development of consumer, medical and industrial products, Scott has participated in all aspects of development for clients including Philips, Johnson & Johnson, and Lilly. He holds a Ph.D. in mechanical engineering from the University of Washington and is a licensed professional engineer.

Nitin Baliga, PhD, SVP & Director at Institute for Systems of Biology

Nitin Baliga develops predictive models of biological networks that catalyze strategies for personalized medicine, infectious diseases treatment, and a sustainable environment. Dr. Baliga has published over 150 peer-reviewed articles in top international journals including Cell, Science and Nature, grossing more than 50,000 citations. In addition to being a Google SciFoo alumnus, Dr. Baliga’s work has been widely profiled in magazines and journals including The Scientist, Genome Web, Wired Magazine, Genetic Engineering News, ArsTechnica, Xconomy, and Nature Methods. He has several patents on diagnostics, prognostics and drug discovery for cancers and tuberculosis, as well as biotechnology solutions for environmental sustainability. He has served in editorial roles on several international journals including BMC Systems Biology, BMC Bioinformatics, Environmental Microbiology, Nature Scientific Data, and Royal Society Open Science. Dr. Baliga has served on the board of Climate Solutions, and has advisory roles on SABs of BlueNalu, Syapse and Hitachi High Tech.

Ron Erickson, CEO at Know Labs

Ron Erickson has over 30 years of experience as a manager, attorney, and senior-level executive. He has been instrumental in building several businesses in his capacity as a senior executive, board member, or advisor. He has raised several hundred million dollars in investment capital and developed extensive global relationships with investment banks, strategic partners, and customers. He has successfully built and lead senior management teams and provided leadership at the Board of Directors level of several public and private companies as lead director and Chairman.

Joe Victor, President & CEO at RareCyte

Joe Victor currently serves as RareCyte President & CEO and has been a Venture Partner/Venture Advisor with 5AM Ventures since 2016. Before joining 5AM Ventures, Mr. Victor was CEO of Startide Sciences, a 5AM Ventures portfolio company chartered to identify and develop innovative technologies in the Life Sciences research tools markets. Before Startide, Mr. Victor served as CEO of DVS Sciences (acquired by Fluidigm Inc.), and Applied Precision Inc (acquired by GE Healthcare). He currently serves as Executive Chairman on the board of Purigen Biosystems and the Boards of RareCyte, Precision Nanosystems, Magnetic Insight, and Glencoe Software. Mr. Victor is also an advisory board member of the Harvard Program in Therapeutic Science and the UC Davis Ecosystem for Biophotonics Innovation. Mr. Victor has also held various executive management and technical positions in the high technology, aviation, and energy markets. Mr. Victor holds an MBA from UCLA and MS and BS degrees in engineering from the University of Washington.

About DeviceConnect: Produced by Life Science WA and Product Creation Studio, this periodic series of educational events explores the most interesting trends in Medical Technology. Scott Thielman, CTO of Product Creation Studio, interviews a panel of experts on a particular topic. Events include audience questions, networking, and light food and drinks. Learn about the series and past events here.

About Seattle Tech Week: Initiated by Madrona Ventures but lead by multiple Seattle Tech stakeholders, the 2nd Annual Seattle Tech Week brings together tech enthusiasts, investors, founders, and innovators at tech companies big and small from around the globe to mingle in Seattle’s buzzing tech ecosystem. One week of independently produced events ranging from pickleball to barbeques to expert panels and happy hours. See the full lineup of Seattle Tech events HERE.

Join us for DeviceConnect on August 2! How AI is Improving Healthcare Diagnostics